ESMO Real World Data and Digital Oncology

NOV 5, 2026 · JOURNAL ARTICLE

Real-world characteristics, testing patterns, and outcomes in patients with tropomyosin receptor kinase fusion cancer from a large pooled clinicogenomic database

ESMO Real World Data and Digital Oncology

Background Tropomyosin receptor kinase (TRK) inhibitors are highly active in neurotrophic tyrosine receptor kinase ( NTRK ) gene fusion cancers. The registrational datasets of the

OCT 29, 2026 · JOURNAL ARTICLE

Abemaciclib plus endocrine therapy in high-risk, node-positive early breast cancer in Italian practice: interim analysis of prospective observational IT-PATH study

ESMO Real World Data and Digital Oncology

Background Abemaciclib plus endocrine therapy (ET) is an established adjuvant treatment for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative

SEP 23, 2026 · JOURNAL ARTICLE

Tumor data extraction from unstructured medical reports: application of an artificial intelligence-enhanced tool in the Eastern Switzerland Cancer Registry.

ESMO Real World Data and Digital Oncology

Population-based cancer registries rely heavily on the manual coding of unstructured medical reports, a process that is both time-consuming and resource-intensive. The number of ca

SEP 23, 2026 · JOURNAL ARTICLE

Understanding return to work after breast cancer through real-world data linkage framework: a Luxembourg digital oncology use case.

ESMO Real World Data and Digital Oncology

Breast cancer (BC) has a substantial impact on women of working age, making return to work (RTW) a critical outcome to evaluate. Research on RTW relies on individual-level real-wor

SEP 22, 2026 · JOURNAL ARTICLE

From electronic health records to real-world evidence: Savana Next-Generation Registry digital solution.

ESMO Real World Data and Digital Oncology

The secondary use of electronic health records (EHRs) offers a major opportunity to generate real-world evidence (RWE) to complement clinical trials and support regulatory and clin

SEP 22, 2026 · JOURNAL ARTICLE

Mapping population-based cancer registries in Europe: coverage, data availability, and capacity for real-world data generation.

ESMO Real World Data and Digital Oncology

Population-based cancer registries (PBCRs) are essential for cancer surveillance and control yet their capacity and coverage vary across Europe. This study presents the first descr

SEP 17, 2026 · JOURNAL ARTICLE

Reporting of National Cancer Registry statistics in Europe: a scoping review.

ESMO Real World Data and Digital Oncology

Background. Population-based cancer registries (PBCRs) play an important role in national cancer control programs by providing data for cancer statistics. The European Network of C

SEP 15, 2026 · JOURNAL ARTICLE

Clinical and genomic determinants of early treatment discontinuation in non-small-cell lung cancer: an analysis of the AACR Project GENIE Biopharma Collaborative NSCLC dataset

ESMO Real World Data and Digital Oncology

Background Early treatment discontinuation (ETD) is common in cancer treatment but understudied. We sought to identify clinical and treatment-related factors associated with ETD in